EQUITY RESEARCH MEMO
AdhexPharma
Generated 5/9/2026
Executive Summary
Conviction (model self-assessment)40/100
AdhexPharma is a private French CDMO founded in 2007, headquartered in Lyon, specializing in transdermal patches and oral films. With over 40 years of combined industry heritage, the company provides full-service contract development and manufacturing, from R&D to commercial production, producing more than 180 million units annually. Its expertise in innovative drug delivery systems positions it as a specialized partner for pharmaceutical companies seeking alternative delivery routes. Despite steady operations, the company's growth trajectory and financial performance are not publicly disclosed, making it a lower-profile entity in the CDMO space.
Locked sections
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)